Comprehensive overview of sell-side research, consensus estimates, and institutional coverage tracking Aevum Zenth Conglomerate.
| Firm / Analyst | Rating | Price Target | Implied Upside | Last Updated | Action |
|---|---|---|---|---|---|
|
Goldman Sachs
M. Reynolds, T. Vance
|
$98.50 | +14.9% | Mar 12, 2026 | View Report → | |
|
J.P. Morgan
S. Okoye
|
$94.00 | +10.1% | Mar 10, 2026 | View Report → | |
|
Morgan Stanley
L. Chen, R. Patel
|
$91.20 | +7.2% | Feb 28, 2026 | View Report → | |
|
Barclays
A. Foster
|
$82.00 | -0.2% | Feb 22, 2026 | View Report → | |
|
UBS
K. Novak
|
$89.50 | +4.8% | Feb 15, 2026 | View Report → | |
|
Jefferies
P. Alvarez
|
$96.00 | +12.3% | Jan 29, 2026 | View Report → | |
|
Cowen
D. Mitchell
|
$83.50 | +1.5% | Jan 20, 2026 | View Report → | |
|
Credit Suisse
E. Dubois
|
$72.00 | -11.3% | Jan 08, 2026 | View Report → |
For research requests, data verification, or interviews with our divisional heads, please contact our dedicated Investor Relations team.
Schedule an Analyst Meeting